Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Protalix Biotherapeutics Inc (NYSE American:PLX)

0.715
Delayed Data
As of Oct 23
 -0.075 / -9.49%
Today’s Change
0.26
Today|||52-Week Range
1.51
+60.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash--55.2M76.7M63.8M
 
 
 
 
Short Term Investment Cash34.4M-31.6M21.6M-13.0M
 
 
 
 
 
Cash & Short Term Investments86.4M55.2M76.7M63.8M
 
 
 
 
 
 
ReceivablesReceivables2.1M1.9M0.00693.0K
 
 
 
 
 
InventoriesInventories8.0M6.7M5.8M5.2M
 
 
 
 
 
 
Current AssetsPrepaid Expenses286.0K369.0K408.0K416.0K
 
 
 
 
 
Other Current Assets1.2M1.4M3.0M1.8M
 
 
 
 
 
Current Assets97.9M65.5M85.9M71.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross32.0M32.7M33.5M34.3M
 
 
 
 
 
Depreciation-18.3M-21.5M-23.8M-25.6M
 
 
 
 
 
Other Assets1.7M1.7M1.6M1.7M
 
 
 
 
 
Total Assets113.3M78.5M97.3M82.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable5.3M4.0M3.6M4.0M
 
 
 
 
 
Short Term Debt0.000.000.0053.9M
 
 
Accrued Expenses4.9M12.8M2.1M4.2M
 
 
 
 
 
Other Current Liabilities19.9M21.0M6.5M7.1M
 
 
 
 
 
Other Liabilities26.7M26.2M11.2M66.2M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt67.0M67.5M72.1M23.6M
 
 
 
 
 
Other Liabilities2.4M912.0K0.000.00
 
 
 
Total Liabilities140.3M134.1M86.4M92.2M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity-26.9M-55.6M10.9M-10.0M
 
 
 
 
 
Total Shareholder Equity-26.9M-55.6M10.9M-10.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding93.6M93.6M99.8M124.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.